title: Chronic lymphocytic leukemia associated with immunotactoid glomerulopathy: a case report of successful treatment with high-dose methylprednisolone in combination with rituximab followed by alemtuzumab.
authors.forename: Januario E
authors.initials: JE
authors.lastname: Castro
authors.forename: Julio A
authors.initials: JA
authors.lastname: Diaz-Perez
authors.forename: Juan S
authors.initials: JS
authors.lastname: Barajas-Gamboa
authors.forename: John M
authors.initials: JM
authors.lastname: Horton
authors.forename: Noel
authors.initials: N
authors.lastname: Weidner
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Kipps
mesh_terms: D000074323:Alemtuzumab; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007136:Immunoglobulins / Q000378:metabolism; D007674:Kidney Diseases / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D007678:Kidney Glomerulus / Q000187:drug effects / Q000276:immunology / Q000473:pathology*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D008875:Middle Aged; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D058846:Antibodies, Monoclonal, Murine-Derived; D007136:Immunoglobulins; D000074323:Alemtuzumab; D000069283:Rituximab; D008775:Methylprednisolone